000			01727 a2200493 4500
005			20250510205516.0
264		0	_c19791121
008			197911s 0 0 eng d
022			_a0004-4172
040			_aNLM _beng _cNLM
100	1		_aHalbhübner, K
245	0	0	_aExperimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs. _h[electronic resource]
260			_bArzneimittel-Forschung _c1978
300			_a1743-52 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_a6-Aminonicotinamide _xadverse effects
650	0	4	_aAnimals
650	0	4	_aAntipsychotic Agents _xpharmacology
650	0	4	_aBaclofen _xpharmacology
650	0	4	_aBrain _xmetabolism
650	0	4	_aBrain Chemistry
650	0	4	_aBromocriptine _xtherapeutic use
650	0	4	_aCentral Nervous System Diseases _xchemically induced
650	0	4	_aDisease Models, Animal
650	0	4	_aDopamine _xpharmacology
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aElectromyography
650	0	4	_aGluconates _xcerebrospinal fluid
650	0	4	_aLevodopa _xpharmacology
650	0	4	_aLisuride _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMotor Neurons _xdrug effects
650	0	4	_aMuscle Contraction _xdrug effects
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aParkinson Disease, Secondary _xchemically induced
650	0	4	_aRNA _xbiosynthesis
650	0	4	_aRats
650	0	4	_aReserpine _xadverse effects
650	0	4	_aSpinal Cord _xanalysis
650	0	4	_aSugar Phosphates _xcerebrospinal fluid
700	1		_aHerken, H
700	1		_aLoos, D
773	0		_tArzneimittel-Forschung _gvol. 28 _gno. 10 _gp. 1743-52
999			_c38525 _d38525